- Janice Hopkins Tanne
- 1New York
GlaxoSmithKline has set aside $3.4bn (£2.1bn; €2.5bn) to cover legal costs in the fourth quarter of last year. That amount wipes out the company’s profit for the fourth quarter, the news agency Reuters has reported. However, a GSK spokeswoman said that she could not give sales projections as they would be reported on 3 February.
In July the company set aside $2.36bn to cover costs related to product liability cases settled or received at that time and other problems, bringing the …